Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice | Zendy

Lauren A.V. Orenstein | Zendy; Tien V. Nguyen | Zendy; Giovanni Damiani | Zendy; Christopher Sayed | Zendy; Gregor B. E. Jemec | Zendy; Iltefat Hamzavi | Zendy

Open Access

Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice

Author(s) -

Lauren A.V. Orenstein,

Tien V. Nguyen,

Giovanni Damiani,

Christopher Sayed,

Gregor B. E. Jemec,

Iltefat Hamzavi

Publication year - 2020

Publication title -

dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.224

H-Index - 92

eISSN - 1421-9832

pISSN - 1018-8665

DOI - 10.1159/000507323

Subject(s) - hidradenitis suppurativa , medicine , adalimumab , infliximab , quality of life (healthcare) , dermatology , medline , disease , intensive care medicine , pathology , nursing , political science , law

Hidradenitis suppurativa (HS) is a chronic painful skin disease that severely impairs patients' quality of life. While high-quality trials of HS therapies remain limited, medical knowledge of best treatment practices is rapidly evolving, leading to the recent publication of multiple international treatment guidelines for HS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research